Literature DB >> 12827661

Aplastic anemia in Down's syndrome.

Keechilat Pavithran, Navamony Laila Raji.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12827661     DOI： 10.1002/ajh.10352

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  4 in total

1.  Immunosuppressive therapy for patients with Down syndrome and idiopathic aplastic anemia.

Authors:  Kyogo Suzuki; Hideki Muramatsu; Yusuke Okuno; Atsushi Narita; Asahito Hama; Yoshiyuki Takahashi; Makoto Yoshida; Yasuo Horikoshi; Ken-Ichiro Watanabe; Kazuko Kudo; Seiji Kojima
Journal:  Int J Hematol       Date:  2016-04-23       Impact factor: 2.490

2.  Epstein-Barr virus-related post-transplant lymphoproliferative disorder occurring after bone marrow transplantation for aplastic anemia in Down's syndrome.

Authors:  Aya Furuya; Mitsuaki Ishida; Keiko Hodohara; Miyuki Yoshii; Hiroko Okuno; Akiko Horinouchi; Ryota Nakanishi; Ayumi Harada; Muneo Iwai; Keiko Yoshida; Akiko Kagotani; Takashi Yoshida; Hidetoshi Okabe
Journal:  Int J Clin Exp Pathol       Date:  2013-12-15

3.  An epidemiological study on anemia among institutionalized people with intellectual and/or motor disability with special reference to its frequency, severity and predictors.

Authors:  Hiroko Ohwada; Takeo Nakayama; Nobuo Nara; Yuji Tomono; Keiko Yamanaka
Journal:  BMC Public Health       Date:  2006-04-03       Impact factor: 3.295

4.  Pure red cell aplasia after 13 years of sodium valproate, and bone marrow suppression after 17 years of carbamazepine.

Authors:  Tiong The; Ratnavalli Kolla; Fitzroy Dawkins; Annapurni Jayam Trouth
Journal:  PLoS Med       Date:  2004-11-30       Impact factor: 11.069
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.